References
- Hultin MB, Sussman II. Postoperative thrombocytopenia in type IIB von Willebrand disease. Am J Hematol 1990;33:64–68.
- Castaman G, Federici AB, Rodeghiero F, Mannucci PM. Von Willebrand’s disease in the year : Towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003;88:94–108.
- Mannucci PM. How I treat patients with von Willebrand disease. Blood 2001;97:1915–1919.
- Castillo R, Monteagudo J, Escolar G, Ordinas A, Magallon M, Martin Villar J. Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients. Blood 1991;77:1901–1905.
- Lethagen S, Carlson M, Hillarp A. A comparative in vitro evaluation of six von Willebrand factor concentrates. Haemo-philia 2004;10:243–249.
- Dobrkovska A, Krzensk U, Chediak JR. Pharmacokinetics, efficacy and safety of Haemate P in von Willebrand disease. Haemophilia 1998;4 (suppl 3):33–39.
- Metzner HJ, Hermentin P, Cuesta-Linker T, Langner S, Muller GH, Friedebold J. Characterization of factor VIII/von Will-ebrand factor concentrates using a modified method of von Willebrand factor multimer analysis. Haemophilia 1998;4\(suppl 3):25–32.
- Ewenstein BM. Use of ristocetin cofactor activity in the management of von Willebrand disease. Haemophilia 2001;7 (suppl 1):10–15.